Imugene Owners | StatInvestor

Health Care & Life Sciences » Biotechnology | Imugene Ltd.

Imugene Ltd. | Ownership

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Private Portfolio Managers Pty Ltd.

223,076,431

6.2%

223,076,431

16.2%

07/09/2018

Platinum Investment Management Ltd.

144,577,570

4.01%

-50,931,076

0.03%

04/03/2018

Schröder Equities GmbH

10,000,000

0.28%

10,000,000

1.23%

06/29/2018

View Profile

Address	62 Lygon Street Carlton Victoria (VIC) 3053 Australia
Employees	-
Website	http://www.imugene.com
Updated	07/08/2019
Imugene Ltd. is a biopharmaceutical company, which engages in the research, development, and commercialisation of health technologies against cancer. Its products include b-cell peptide cancer vaccines, arginine modulators, and mimotopes. The company was founded on May 30, 1986 and is headquartered in Carlton, Australia.